• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION AVALUS AORTIC TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION AVALUS AORTIC TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 40017
Device Problems Partial Blockage (1065); Degraded (1153); Perivalvular Leak (1457)
Patient Problems Aortic Regurgitation (1716); Endocarditis (1834); Insufficiency, Valvular (1926); Vascular System (Circulation), Impaired (2572)
Event Date 01/30/2020
Event Type  Injury  
Manufacturer Narrative
Citation: faure m., et al.Surgically implanted aortic valve bioprostheses deform after implantation: insights from computed tomography.Eur radiol, 30 jan 2020; https://doi.Org/10.1007/s00330-019-06634-6 earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding the use of multi-detector row computerized tomography (mdct) to determine the prevalence and degree of aortic bioprosthetic valve deformation.All data were retrospectively collected from multiple centers between 2007 and 2019.The study population included 152 patients (demographics not provided), eight of whom were implanted with medtronic mosaic bioprosthetic valves (no serial numbers provided) and one implanted with a medtronic avalus bioprosthetic valve (no serial numbers provided).Among all patients adverse events included: suspected endocarditis, suspected aortic regurgitation, suspected obstruction, and suspected bioprosthetic valve dysfunction requiring intervention.Based on the available information medtronic product may have been associated with the adverse events.Among all patients malfunctions included: bioprosthetic valve geometrical deformation/eccentricity.Based on the available information medtronic product may have been associated with the malfunctions.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVALUS AORTIC TISSUE VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key9838923
MDR Text Key191376558
Report Number2025587-2020-00794
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 03/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number40017
Device Catalogue Number40017
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/18/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-